Healthy Business Matters: MSK Is The Trojan Horse For Metabolic Risk

Episode notes

Most employers believe they have separate healthcare problems: An MSK problem An obesity problem A GLP-1 problem A pharmacy trend problem They don’t. They have a pathway problem. In this episode, we connect the dots most benefit strategies keep siloed and make the case that musculoskeletal pain is often the front door to long-term metabolic dysfunction. When something hurts, people move less. When movement drops, insulin sensitivity declines. When metabolism shifts, risk compounds. Months or years later, that shows up in a completely different budget category. By the time you’re debating GLP-1 spend, the pathway was already set. GLP-1 didn’t create your metabolic risk. It revealed it.

• How Employers Can Get Better Healthcare for Less: Breaking the Status Quo with Dan Cosgrove66 / 100
• Healthy Business Podcast: Movement Capacity Is the Missing Variable in Your Metabolic Strategy87 / 100
• Healthy Business Matters: GLP-1's Alone Are Not a Metabolic Strategy
• Healthy Business Matters: Where Care Starts is Where Costs Are Decided
• Healthy Business Matters : Why so many 'Proactive' Health Programs Stay Reactive